Although regulation of CD44 expression in head and neck cancers remains incompletely understood, recent studies have demonstrated and suggested that the increased CD44 expression in OSCC is correlated with increased metastasis, recurrence, resistance to chemo- and radiation therapy, and decreased survival [13], [15]–[17]. Here, CD44 is linked to head and neck cancer.